Tagged - COVID-19
COVID-19
Vaccine trials and tribulations: The questions that really matter
The biggest threat to the health and safety of the public right now is bureaucracy.
COVID-19
A letter from the Editor
So why do we do this? Why bother adding our amateur-hour content to the information overload? Because it's fun to care.
COVID-19
UR revamps orientation to be mostly online
“The orientation this year is going well,” said sophomore Waleed Nadeem, one of the six orientation leaders. “We are doing it in the hybrid model, with both virtual and in-person. It’s a new experience, and we are trying to reimagine the events.”
COVID-19
Fall 2020 plans finalized pending governor’s approval
The University’s plan is subject to change pending its accordance with a set of yet-to-be-released guidelines from New York Governor Andrew Cuomo.
COVID-19
UR tentatively starts reopening research labs
The labs have several social distancing measures in place, like limiting the number of people in labs, strategically scheduling shifts, and reorganizing spaces.
COVID-19
Employee furloughs and pay cuts spur calls for equity
Several groups have been calling for administration to take a second look at these decisions.
COVID-19
Fall 2020 plans tentatively announced in the face of COVID-19
Classes will start in late August, and be offered in-person and online through Thanksgiving, according to the email.
COVID-19
Meliora Weekend canceled for Fall 2020
The announcement, written by Senior Vice President for University Advancement Thomas Farrell, says that the University canceled the event due to concerns surrounding COVID-19.
Commencement
UR graduates seniors online
For the Class of 2020, graduation was delivered through videos, written messages, Zoom meetings, and social media filters. The speeches,…
COVID-19
URMC studies COVID-19 vaccines, social distancing
Though testing will take place with multiple visits over a period of two years, it’s possible that the resulting vaccine will be ready for emergency use before then, with plans in place for millions of doses to be available by the end of the year, and production being upped to hundreds of millions in 2021.
